LEGN

$0.00

(

+0.00%

)
Quote details

stock

Legend Biotech Corp

NASDAQ | LEGN

33.36

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 26, 2025)

$6.06B

Market Cap

-

P/E Ratio

-1.78

EPS

$51.77

52 Week High

$27.34

52 Week Low

HEALTHCARE

Sector

LEGN Chart

Recent Chart
Price Action

LEGN Technicals

Tags:

LEGN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $393M
Total Revenue $627M
Cost Of Revenue $235M
Costof Goods And Services Sold $235M
Operating Income -$303M
Selling General And Administrative $137M
Research And Development $414M
Operating Expenses $696M
Investment Income Net -
Net Interest Income $40M
Interest Income $61M
Interest Expense $22M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $23M
Income Before Tax -$158M
Income Tax Expense $19M
Interest And Debt Expense -
Net Income From Continuing Operations -$177M
Comprehensive Income Net Of Tax -
Ebit -$137M
Ebitda -$113M
Net Income -$177M

Revenue & Profitability

Earnings Performance

LEGN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.7B
Total Current Assets $1.3B
Cash And Cash Equivalents At Carrying Value $287M
Cash And Short Term Investments $287M
Inventory $24M
Current Net Receivables $125M
Total Non Current Assets $386M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $174M
Intangible Assets Excluding Goodwill $174M
Goodwill -
Investments -
Long Term Investments $4.4M
Short Term Investments $836M
Other Current Assets $12M
Other Non Current Assets -
Total Liabilities $630M
Total Current Liabilities $278M
Current Accounts Payable $37M
Deferred Revenue -
Current Debt -
Short Term Debt $9.6M
Total Non Current Liabilities $352M
Capital Lease Obligations $49M
Long Term Debt $301M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $351M
Other Current Liabilities $160M
Other Non Current Liabilities -
Total Shareholder Equity $1B
Treasury Stock -
Retained Earnings -$1.7B
Common Stock $37K
Common Stock Shares Outstanding $91M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$144M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $23M
Capital Expenditures $14M
Change In Receivables -
Change In Inventory -$17M
Profit Loss -
Cashflow From Investment -$851M
Cashflow From Financing $5.7M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$158M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $393M
Total Revenue $627M
Cost Of Revenue $235M
Costof Goods And Services Sold $235M
Operating Income -$303M
Selling General And Administrative $137M
Research And Development $414M
Operating Expenses $696M
Investment Income Net -
Net Interest Income $40M
Interest Income $61M
Interest Expense $22M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $23M
Income Before Tax -$158M
Income Tax Expense $19M
Interest And Debt Expense -
Net Income From Continuing Operations -$177M
Comprehensive Income Net Of Tax -
Ebit -$137M
Ebitda -$113M
Net Income -$177M

LEGN News

LEGN Profile

Legend Biotech Corp Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Legend Biotech Corporation is a clinical-stage biopharmaceutical company specializing in the discovery and development of innovative cell therapies targeting oncology and other significant medical indications. With a strong focus on advancing its proprietary CAR-T cell therapy platform, the company is positioned at the forefront of the rapidly evolving field of immuno-oncology. Legend Biotech's strategic collaborations and commitment to rigorous clinical research enhance its potential to deliver transformative therapies, ultimately addressing unmet medical needs and improving patient outcomes. As it progresses through pivotal clinical trials, Legend Biotech presents significant investment opportunities in the biopharmaceutical sector.

DVLT
+30.57%
$1.09
INTC
+8.87%
$33.99
GPUS
+19.56%
$0.45
CGBS
-39.47%
$0.03
NVDA
+0.40%
$177.69
DFLI
+38.45%
$0.52
SNAP
-0.78%
$8.26
NUAI
+33.33%
$1.84
CJET
+10.63%
$0.17
F
+3.39%
$12.01
DNN
-3.14%
$2.77
PSTV
+9.60%
$0.61
APLT
+121.34%
$1.24
TSLA
+4.01%
$440.40
RGTI
-2.86%
$31.18
BIAF
+55.13%
$5.29
YAAS
-8.19%
$0.09
PLUG
+0.42%
$2.37
CIFR
-1.62%
$11.47
NIO
+4.91%
$7.47
ADAP
+15.74%
$0.14
AAL
-0.70%
$11.31
WOK
-5.22%
$0.08
NEHC
+49.83%
$1.38
RIG
+0.79%
$3.18
IONZ
+5.83%
$4.34
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
BBD
-2.09%
$3.27
MRM
+102.75%
$2.94
QBTS
+1.55%
$26.75
VALE
-1.74%
$10.70
IREN
-9.57%
$41.86
BTG
+1.54%
$4.92
BLMZ
+12.51%
$0.20
QUBT
-2.11%
$20.14
LYT
-16.77%
$0.09
AMZN
-0.93%
$218.15
MARA
+0.37%
$16.13
KVUE
+1.54%
$16.42
CAN
-10.64%
$0.79
RIOT
+5.67%
$17.69
KDLY
+7.69%
$1.26
RXRX
-5.12%
$4.63
AAPL
-0.54%
$255.46
ATCH
-4.22%
$0.79
SOUN
-2.50%
$15.94
PLTR
-0.86%
$177.57
BITF
-5.22%
$2.54
TLRY
-3.36%
$1.14
FCX
+1.14%
$35.74
BMNR
+1.69%
$50.41
QS
+0.08%
$12.50
RMBL
+60.50%
$3.21
BURU
-3.83%
$0.13
ETHD
-5.95%
$3.95
IXHL
-0.01%
$0.59
SHOT
+12.24%
$0.28
GRAB
-2.24%
$6.11
ADD
-25.47%
$0.05
RR
+2.68%
$4.20
CLSK
-5.32%
$13.68
RIVN
-0.95%
$15.59
SOFI
-0.49%
$27.98
ONDS
-1.16%
$7.66
CVE
+0.36%
$17.76
RAYA
-3.15%
$0.04
SRM
+53.27%
$10.30
PFE
+0.65%
$23.75
ACHR
-0.53%
$9.27
BULL
+2.35%
$14.98
IONQ
-3.09%
$67.28
BB
+6.34%
$4.94
JOBY
+1.63%
$16.12
NOK
-0.53%
$4.65
AMD
-1.12%
$159.46
CRWV
-4.98%
$120.34
CLF
+2.52%
$12.37
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BTE
+2.64%
$2.52
WBD
-0.82%
$19.61
WLGS
-5.57%
$0.04
HIMS
+6.39%
$58.38
ABEV
+0.21%
$2.30
AQMS
+48.37%
$7.30
MRVL
-0.76%
$83.17
ETWO
0.00%
$3.30
HBAN
+0.57%
$17.42
ORCL
-2.70%
$283.45
AG
+4.15%
$12.15
HOOD
-0.70%
$121.78
AIIO
-15.63%
$2.04
SDM
-86.40%
$1.85
OKLO
-7.21%
$110.53
ITUB
+0.55%
$7.24
MU
+0.28%
$157.27
AFMD
-34.94%
$0.18
AGNC
+0.81%
$9.84
SMCI
-0.90%
$45.82
DVLT
+30.57%
$1.09
INTC
+8.87%
$33.99
GPUS
+19.56%
$0.45
CGBS
-39.47%
$0.03
NVDA
+0.40%
$177.69
DFLI
+38.45%
$0.52
SNAP
-0.78%
$8.26
NUAI
+33.33%
$1.84
CJET
+10.63%
$0.17
F
+3.39%
$12.01
DNN
-3.14%
$2.77
PSTV
+9.60%
$0.61
APLT
+121.34%
$1.24
TSLA
+4.01%
$440.40
RGTI
-2.86%
$31.18
BIAF
+55.13%
$5.29
YAAS
-8.19%
$0.09
PLUG
+0.42%
$2.37
CIFR
-1.62%
$11.47
NIO
+4.91%
$7.47
ADAP
+15.74%
$0.14
AAL
-0.70%
$11.31
WOK
-5.22%
$0.08
NEHC
+49.83%
$1.38
RIG
+0.79%
$3.18
IONZ
+5.83%
$4.34
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
BBD
-2.09%
$3.27
MRM
+102.75%
$2.94
QBTS
+1.55%
$26.75
VALE
-1.74%
$10.70
IREN
-9.57%
$41.86
BTG
+1.54%
$4.92
BLMZ
+12.51%
$0.20
QUBT
-2.11%
$20.14
LYT
-16.77%
$0.09
AMZN
-0.93%
$218.15
MARA
+0.37%
$16.13
KVUE
+1.54%
$16.42
CAN
-10.64%
$0.79
RIOT
+5.67%
$17.69
KDLY
+7.69%
$1.26
RXRX
-5.12%
$4.63
AAPL
-0.54%
$255.46
ATCH
-4.22%
$0.79
SOUN
-2.50%
$15.94
PLTR
-0.86%
$177.57
BITF
-5.22%
$2.54
TLRY
-3.36%
$1.14
FCX
+1.14%
$35.74
BMNR
+1.69%
$50.41
QS
+0.08%
$12.50
RMBL
+60.50%
$3.21
BURU
-3.83%
$0.13
ETHD
-5.95%
$3.95
IXHL
-0.01%
$0.59
SHOT
+12.24%
$0.28
GRAB
-2.24%
$6.11
ADD
-25.47%
$0.05
RR
+2.68%
$4.20
CLSK
-5.32%
$13.68
RIVN
-0.95%
$15.59
SOFI
-0.49%
$27.98
ONDS
-1.16%
$7.66
CVE
+0.36%
$17.76
RAYA
-3.15%
$0.04
SRM
+53.27%
$10.30
PFE
+0.65%
$23.75
ACHR
-0.53%
$9.27
BULL
+2.35%
$14.98
IONQ
-3.09%
$67.28
BB
+6.34%
$4.94
JOBY
+1.63%
$16.12
NOK
-0.53%
$4.65
AMD
-1.12%
$159.46
CRWV
-4.98%
$120.34
CLF
+2.52%
$12.37
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BTE
+2.64%
$2.52
WBD
-0.82%
$19.61
WLGS
-5.57%
$0.04
HIMS
+6.39%
$58.38
ABEV
+0.21%
$2.30
AQMS
+48.37%
$7.30
MRVL
-0.76%
$83.17
ETWO
0.00%
$3.30
HBAN
+0.57%
$17.42
ORCL
-2.70%
$283.45
AG
+4.15%
$12.15
HOOD
-0.70%
$121.78
AIIO
-15.63%
$2.04
SDM
-86.40%
$1.85
OKLO
-7.21%
$110.53
ITUB
+0.55%
$7.24
MU
+0.28%
$157.27
AFMD
-34.94%
$0.18
AGNC
+0.81%
$9.84
SMCI
-0.90%
$45.82

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.